» Articles » PMID: 37876008

Insights into the Diagnosis, Vaccines, and Control of Taenia Solium, a Zoonotic, Neglected Parasite

Overview
Journal Parasit Vectors
Publisher Biomed Central
Date 2023 Oct 25
PMID 37876008
Authors
Affiliations
Soon will be listed here.
Abstract

Taenia solium taeniasis/cysticercosis (TSTC) is a foodborne, zoonotic neglected tropical disease affecting predominately low- and middle-income countries. Humans are definitive hosts for T. solium, whereas pigs act as intermediate hosts. Taeniasis, i.e. intestinal infection with adult T. solium in the human host, occurs through ingestion of undercooked pork infected with the larval stage (porcine cysticercosis, PCC). Human cysticercosis occurs after humans ingest T. solium eggs, acting as accidental intermediate hosts. Migration of cysticerci to the human brain results in neurocysticercosis (NCC), manifesting in a variety of clinical symptoms, most notably epilepsy. NCC is the leading cause of acquired epilepsy cases in endemic areas. PCC results in reduced pork value because of condemnation or the risk of condemnation of the meat. Available serological diagnostic tests for porcine and human cysticercosis are characterized by low sensitivity and are not cost-effective. An effective vaccine for T. solium cysticercosis in pigs has been developed, although it is not yet commercially available in all endemic countries, and still no vaccine is available for use in humans. This primer highlights the recent development in the field of diagnostic tests and vaccine production and explores possible strategies for future control and eradication of T. solium. In the absence of highly specific diagnostic tests and human vaccines, treatment of infected pigs and tapeworm carriers and prevention of disease transmission remain the principal means to interrupt the zoonotic cycle of T. solium in endemic countries.

Citing Articles

Proceedings from the CIHLMU International Health Symposium 2023: "One Health Approach to Neglected Tropical Diseases".

Hayibor K, Pamba D, Banze D, Mfinanga A, Hanago G, Singh A BMC Proc. 2025; 19(Suppl 5):2.

PMID: 39979937 PMC: 11843733. DOI: 10.1186/s12919-025-00317-5.


From laboratory to clinical practice: an update of the immunological and molecular tools for neurocysticercosis diagnosis.

Toribio L, Bustos J, Garcia H Front Parasitol. 2025; 3():1394089.

PMID: 39817165 PMC: 11732113. DOI: 10.3389/fpara.2024.1394089.


Treatment outcome in patients with spinal neurocysticercosis: a systematic review of published cases and case series.

Garg R, Rizvi I, Nigam H, Pandey S, Uniyal R Future Microbiol. 2024; 20(1):45-56.

PMID: 39545648 PMC: 11730807. DOI: 10.1080/17460913.2024.2428526.

References
1.
Coral-Almeida M, Gabriel S, Abatih E, Praet N, Benitez W, Dorny P . Taenia solium Human Cysticercosis: A Systematic Review of Sero-epidemiological Data from Endemic Zones around the World. PLoS Negl Trop Dis. 2015; 9(7):e0003919. PMC: 4493064. DOI: 10.1371/journal.pntd.0003919. View

2.
Ouma E, Dione M, Mtimet N, Lule P, Colston A, Adediran S . Demand for Cysticercosis Vaccine: Lessons and Insights From the Pig Production and Trading Nodes of the Uganda Pig Value Chain. Front Vet Sci. 2021; 8:611166. PMC: 8110731. DOI: 10.3389/fvets.2021.611166. View

3.
Mendlovic F, Cruz-Rivera M, Diaz-Gandarilla J, Flores-Torres M, Avila G, Perfiliev M . Orally administered Taenia solium Calreticulin prevents experimental intestinal inflammation and is associated with a type 2 immune response. PLoS One. 2017; 12(10):e0186510. PMC: 5643116. DOI: 10.1371/journal.pone.0186510. View

4.
Hernandez-Gonzalez A, Gonzalez-Bertolin B, Urrea L, Fleury A, Ferrer E, Siles-Lucas M . Multiple-bead assay for the differential serodiagnosis of neglected human cestodiases: Neurocysticercosis and cystic echinococcosis. PLoS Negl Trop Dis. 2022; 16(1):e0010109. PMC: 8759687. DOI: 10.1371/journal.pntd.0010109. View

5.
Illescas O, Carrero J, Bobes R, Flisser A, Rosas G, Laclette J . Molecular characterization, functional expression, tissue localization and protective potential of a Taenia solium fatty acid-binding protein. Mol Biochem Parasitol. 2012; 186(2):117-25. DOI: 10.1016/j.molbiopara.2012.10.002. View